SUPN logo

Supernus Pharmaceuticals, Inc. (SUPN)

Profile

Full Name

Supernus Pharmaceuticals, Inc.

Ticker

NASDAQ: SUPN

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

May 1, 2012

Indexes

Not included

Website

https://www.supernus.com

Employees

674

Key Details

Price

$35.51(+1.17%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$661.82M(+8.94% YoY)

Annual EPS

$1.32(+6500.00% YoY)

PE ratio

31.99

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $35.51
    SUPN price is $35.51

    30-Day Relative Volume

    1.08
    SUPN 30-day relative volume is 1.08

    Price Performance

    Price Most recent change

    +1.17%
    SUPN price was up +1.17% on Aug 1, 2025

    Price YTD change

    -1.8%
    SUPN price is down -1.8% since January 1st

    Price 1-year change

    +20.09%
    SUPN price is up +20.09% year-on-year

    Price 3-year change

    +12.73%
    SUPN price is up +12.73% over the past 3 years

    Price Range

    Price All-time high

    $61.25
    SUPN price is currently -42.02% below its historical high of $61.25

    Price 3-year low

    $21.99
    SUPN price is currently +61.48% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.99B
    SUPN market capitalization is $1.99 billion

    Market cap 3-year change

    +17.99%
    SUPN market capitalization is up +17.99% over the past 3 years

    Market cap All-time high

    $3.12B
    SUPN market capitalization is currently -36.34% below its historical high of $3.12 billion

    Market cap sector rank

    82.41%
    SUPN market capitalization is higher than 82.41% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.6%
    SUPN shares outstanding is up +1.6% year-on-year

    Shares Outstanding 3-Year Change

    +4.66%
    SUPN shares outstanding is up +4.66% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.44
    SUPN beta is 0.44

    200-day SMA

    $34.19
    SUPN price is currently +3.86% above its 200-day simple moving average

    50-day SMA

    $32.63
    SUPN price is currently +8.81% above its 50-day simple moving average

    RSI

    69.56
    SUPN 14-day relative strength index is 69.56

    Volume

    1.08
    SUPN 30-day relative volume is 1.08

    ATR

    $1.16
    SUPN average true range is $1.16

    10-day Historical Volatility

    29.00%
    SUPN 10-day historical volatility is 29.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $661.82M
    SUPN annual revenue is $661.82 million

    Revenue Analysts estimate

    $636.35M
    SUPN annual revenue is currently +4.00% higher than the consensus analysts' forecast

    Revenue 1-year change

    +8.94%
    SUPN annual revenue is up +8.94% year-on-year

    Revenue Sector rank

    76.32%
    SUPN annual revenue is higher than 76.32% of companies in Healthcare sector

    EPS

    EPS

    $1.32
    SUPN annual earnings per share is $1.32

    EPS Analysts estimate

    $1.97
    SUPN annual earnings per share is currently -32.82% lower than the consensus analysts' forecast

    EPS 1-year change

    +6500%
    SUPN annual earnings per share is up +6500% year-on-year

    EPS Sector rank

    90.27%
    SUPN annual earnings per share is higher than 90.27% of companies in Healthcare sector

    Profit

    Gross profit

    $583.91M
    SUPN annual gross profit is $583.91 million

    Gross margin

    88.23%
    SUPN annual gross profit margin is 88.23%

    Operating profit

    $75.56M
    SUPN annual operating income is $75.56 million

    Operating margin

    11.42%
    SUPN annual operating profit margin is 11.42%

    Net income

    $73.86M
    SUPN annual net profit is $73.86 million

    Net margin

    11.16%
    SUPN annual net profit margin is 11.16%

    Expenses

    Total expenses

    $586.26M
    SUPN annual total expenses is $586.26 million

    Operating expenses

    $508.36M
    SUPN annual total operating expenses is $508.36 million

    Cost of goods sold

    $77.91M
    SUPN annual cost of goods sold is $77.91 million

    Selling, general & administrative expenses

    $321.58M
    SUPN annual SGA is $321.58 million

    Depreciation and amortization

    $80.41M
    SUPN annual depreciation & amortization is $80.41 million

    Interest expense

    $0.00
    SUPN annual interest expense is $0.00

    Income tax

    $24.00M
    SUPN annual income tax is $24.00 million

    EBIT & EBITDA

    EBIT

    $97.87M
    SUPN annual earnings before interest & taxes is $97.87 million

    EBITDA

    $178.28M
    SUPN annual EBITDA is $178.28 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.37B
    SUPN annual total assets is $1.37 billion

    Non current assets

    $682.00M
    SUPN annual long term assets is $682.00 million

    Current assets

    $686.07M
    SUPN annual total current assets is $686.07 million

    Cash and cash equivalents

    $69.33M
    SUPN annual cash & cash equivalents is $69.33 million

    Accounts receivable

    $142.08M
    SUPN annual accounts receivable is $142.08 million

    Inventory

    $54.29M
    SUPN annual inventory is $54.29 million

    Liabilities

    Total liabilities

    $332.34M
    SUPN annual total liabilities is $332.34 million

    Long term liabilities

    $39.94M
    SUPN annual total long term liabilities is $39.94 million

    Current liabilities

    $292.40M
    SUPN annual total current liabilities is $292.40 million

    Accounts payable

    $4.59M
    SUPN annual accounts payable is $4.59 million

    Debt

    Total debt

    $34.27M
    SUPN annual total debt is $34.27 million

    Total debt 1-year change

    -17.47%
    SUPN annual total debt is down -17.47% year-on-year

    Long term debt

    $27.38M
    SUPN annual long term debt is $27.38 million

    Short term debt

    $6.89M
    SUPN annual short term debt is $6.89 million

    Equity & Capital

    Shareholders equity

    $1.04B
    SUPN annual stockholders equity is $1.04 billion

    Book value

    $1.04B
    SUPN annual book value is $1.04 billion

    Retained earnings

    $556.43M
    SUPN annual retained earnings is $556.43 million

    Working capital

    $393.67M
    SUPN annual working capital is $393.67 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $171.95M
    SUPN annual cash flow from operations is $171.95 million

    Cash from operations 1-year change

    +54.79%
    SUPN annual cash flow from operations is up +54.79% year-on-year

    Cash from investing

    -$189.87M
    SUPN annual cash flow from investing activities is -$189.87 million

    Cash from investing 1-year change

    -170.65%
    SUPN annual cash flow from investing activities is down -170.65% year-on-year

    Cash from financing

    $12.19M
    SUPN annual cash flow from financing activities is $12.19 million

    Cash from financing 1-year change

    +103.06%
    SUPN annual cash flow from financing activities is up +103.06% year-on-year

    CAPEX

    CAPEX

    $725.00K
    SUPN annual capital expenditures is $725.00 thousand

    CAPEX 1-year change

    +31.58%
    SUPN annual capital expenditures is up +31.58% year-on-year

    Free Cash Flow

    Free cash flow

    $171.23M
    SUPN annual free cash flow is $171.23 million

    Free cash flow 1-year change

    +54.91%
    SUPN annual free cash flow is up +54.91% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    88.23%
    SUPN annual gross profit margin is 88.23%

    Operating margin

    11.42%
    SUPN annual operating profit margin is 11.42%

    Net margin

    11.16%
    SUPN annual net profit margin is 11.16%

    ROA & ROE

    ROA

    5.58%
    SUPN annual return on assets is 5.58%

    ROE

    7.55%
    SUPN annual return on equity is 7.55%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    31.99
    SUPN price to earnings ratio is 31.99

    PE ratio Sector rank

    62.84%
    SUPN price to earnings ratio is higher than 62.84% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.93
    SUPN price to book ratio is 1.93

    PB ratio Sector rank

    55.6%
    SUPN price to book ratio is higher than 55.6% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.98
    SUPN price to sales ratio is 2.98

    PS ratio Sector rank

    49.73%
    SUPN price to sales ratio is higher than 49.73% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.90B
    SUPN enterprise value is $1.90 billion

    Enterprise value Sector rank

    81.26%
    SUPN enterprise value is higher than 81.26% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    10.88
    SUPN EV/EBITDA is 10.88

    EV/EBITDA Sector rank

    84.7%
    SUPN EV/EBITDA is higher than 84.7% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.35
    SUPN annual current ratio is 2.35

    Quick ratio

    2.16
    SUPN annual quick ratio is 2.16

    Leverage

    Debt to equity

    0.00
    SUPN annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    SUPN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    8
    SUPN piotroski f-score is 8

    Altman Z-Score

    5.22
    SUPN altman z-score is 5.22

    Analyst ratings

    Recent major analysts updates

    Feb 26, 25 Cantor Fitzgerald
    Neutral
    Feb 19, 25 Cantor Fitzgerald
    Neutral
    Sep 11, 24 Piper Sandler
    Neutral
    Feb 28, 24 Piper Sandler
    Overweight
    Nov 9, 23 Piper Sandler
    Overweight
    Oct 25, 23 Piper Sandler
    Overweight
    May 10, 23 Piper Sandler
    Overweight
    Jan 23, 23 Piper Sandler
    Overweight
    Aug 31, 22 Piper Sandler
    Overweight
    Apr 13, 21 Jefferies
    Buy

    Institutional Ownership

    Screeners with SUPN included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Supernus Pharmaceuticals, Inc.?
    • Does Supernus Pharmaceuticals, Inc. pay dividends?
    • What sector is Supernus Pharmaceuticals, Inc. in?
    • What industry is Supernus Pharmaceuticals, Inc. in?
    • What country is Supernus Pharmaceuticals, Inc. based in?
    • When did Supernus Pharmaceuticals, Inc. go public?
    • Is Supernus Pharmaceuticals, Inc. in the S&P 500?
    • Is Supernus Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Supernus Pharmaceuticals, Inc. in the Dow Jones?
    • When was Supernus Pharmaceuticals, Inc.'s last earnings report?
    • When does Supernus Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Supernus Pharmaceuticals, Inc.?

    The ticker symbol for Supernus Pharmaceuticals, Inc. is NASDAQ:SUPN

    Does Supernus Pharmaceuticals, Inc. pay dividends?

    No, Supernus Pharmaceuticals, Inc. does not pay dividends

    What sector is Supernus Pharmaceuticals, Inc. in?

    Supernus Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Supernus Pharmaceuticals, Inc. in?

    Supernus Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Supernus Pharmaceuticals, Inc. based in?

    Supernus Pharmaceuticals, Inc. is headquartered in United States

    When did Supernus Pharmaceuticals, Inc. go public?

    Supernus Pharmaceuticals, Inc.'s initial public offering (IPO) was on May 1, 2012

    Is Supernus Pharmaceuticals, Inc. in the S&P 500?

    No, Supernus Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Supernus Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Supernus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Supernus Pharmaceuticals, Inc. in the Dow Jones?

    No, Supernus Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Supernus Pharmaceuticals, Inc.'s last earnings report?

    Supernus Pharmaceuticals, Inc.'s most recent earnings report was on May 6, 2025

    When does Supernus Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Supernus Pharmaceuticals, Inc. is August 5, 2025
    On this page